Ionis shares positive clinical update from ongoing trial of ION582 for Angelman syndrome
Part 1 of HALOS trial evaluating ION582 has completed enrollment with results expected in mid-2024ION582 has been generally well tolerated at all dose levels, and participants are continuing to Part 2, the long-term extension portion of the studyEncouraging EEG and clinical observations support cont
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation – IART
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART). Such investors are advised to contact Robert S. Willoughby at newaction@po
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PureCycle Technologies, Inc. – PCT
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of PureCycle Technologies, Inc. (“PureCycle” or the “Company”) (NASDAQ: PCT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nikola Corporation of Class Action Lawsuit and Upcoming Deadline – NKLA
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Nikola Corporation (“Nikola” or the “Company”) (NASDAQ: NKLA) and certain officers. The class action, filed in the United States District Court for the Dist
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Advance Auto Parts, Inc. of Class Action Lawsuit and Upcoming Deadline- AAP
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Advance Auto Parts, Inc. (“AAP” or the “Company”) (NYSE: AAP) and certain officers. The class action, filed in the United States District Court for the
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – OTLK
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and certain officers. The class action, filed in the United States District Court
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. – BCLI
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Barclays PLC – BCS
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DISH Network Corporation – DISH
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DISH Network Corporation (“DISH” or the “Company”) (NASDAQ: DISH). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529
